Nuvaxovid 2026-2027
RxNorm concept 2751664, brand name (bn).
- RxCUI
- 2751664
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2751664 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 (PIN, has precise ingredient)
- SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.01 MG/ML [Nuvaxovid 2026-2027] (SBDC, ingredient of)
- Nuvaxovid 2026-2027 Injectable Product (SBDG, ingredient of)
- SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein Prefilled Syringe [Nuvaxovid 2026-2027] (SBDF, ingredient of)
- 0.5 ML SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.01 MG/ML Prefilled Syringe [Nuvaxovid 2026-2027] (SBD, ingredient of)
- SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2751664 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2751664 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2751664. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.